Echo contrast-enhanced power doppler ultrasonography for assessment of angiogenesis in renal cell carcinoma

Journal of Ultrasound in Medicine

Volumn 24, Issue 6, 2005, Pages 747-753

  Kabakci, Neslihan ^a   Igci, Enis ^a   Secil, Mustafa ^a   Yorukoglu, Kutsal ^a   Mungan, Ugur ^a   Celebi, Ilhan ^a   Kirkali, Ziya ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Echo contrast agent; Power Doppler ultrasonography; Renal cell carcinoma

Indexed keywords

CELLS; GENES; MEDICAL IMAGING; PATHOLOGY; RADIOLOGY; TUMORS;

ANGIOGENESIS; MICROVESSEL DENSITY (MVD); POWER DOPPLER ULTRASONOGRPAHY; ULTRASONOGRAPHY;

ULTRASONICS;

CONTRAST MEDIUM;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; KIDNEY CARCINOMA; MALE; MICROCIRCULATION; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; RETROSPECTIVE STUDY; TUMOR GROWTH;

EID: 19544379011     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2005.24.6.747     Document Type: Article

References (34)

1. Li WW. Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. Acad Radiol 2000; 7:800-811.
2. Folkman J, Beckner K. Angiogenesis imaging. Acad Radiol 2000; 7:783-785.
3. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143:401-409.
4. Yoshino S, Kato M, Okada K. Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol 1995; 2:156-160.
5. Strohmeyer D. Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer. Anticancer Res 1999; 19:1557-1561.
6. Delorme S, Knopp MV. Non-invasive vascular imaging: assessing tumour vascularity. Eur Radiol 1998; 8:517-527.
7. Yang WT, Tse GM, Lam PK, Metreweli C, Chang J. Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. J Ultrasound Med 2002; 21:1227-1235.
8. Shigeno K, Igawa M, Shiina H, Kishi H, Urakami S. Transrectal colour Doppler ultrasonography for quantifying angiogenesis in prostate cancer. BJU Int 2003; 91:223-226.
9. Martinoli C, Pretolesi F, Crespi G, et al. Power Doppler sonography: clinical applications. Eur J Radiol 1998; 27(suppl 2):S133-S140.
10. Lassau N, Koscielny S, Opolon P, et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol 2001; 36:50-55.
11. Hosten N, Puls R, Lemke AJ, et al. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions. J Clin Ultrasound 1999; 27:107-115.
12. Iordanescu I, Becker C, Zetter B, Dunning P, Taylor GA. Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors. Radiology 2002; 222:460-467.
13. Tang J, Li S, Li J, et al. Correlation between prostate cancer grade and vascularity on color Doppler imaging: preliminary findings. J Clin Ultrasound 2003; 31:61-68.
14. Tang J, Li S, Li J, et al. Evaluation of the effect of protamine on human prostate carcinoma PC-3m using contrast-enhanced Doppler ultrasound. J Urol 2003; 170:611-614.
15. Fox SB, Leed RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J Pathol 1995; 177:275-283.
16. Fleischer AC. Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications. J Ultrasound Med 2000; 19:55-61.
17. Ferrara KW, Merritt CR, Burns PN, Foster FS, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. Acad Radiol 2000; 7:824-839.
18. Hosoki T, Mitomo M, Chor S, Miyahara N, Ohtani M, Morimoto K. Visualization of tumor vessels in hepatocellular carcinoma: power Doppler compared with color Doppler and angiography. Acta Radiol 1997; 38:422-427.
19. Rubin JM. Power Doppler. Eur Radiol 1999; 9(suppl 3):S318-S322.
20. Meyerowitz CB, Fleischer AC, Pickens DR, et al. Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: preliminary results. J Ultrasound Med 1996; 15:827-833.
21. Fleischer AC, Wojcicki WE, Donnelly EF, et al. Quantified color Doppler sonography of tumor vascularity in an animal model. J Ultrasound Med 1999; 18:547-551.
22. Louvar E, Littrup PJ, Goldstein A, Yu L, Sakr W, Grignon D. Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 1998; 83:135-140.
23. Cosgrove DO, Bamber JC, Davey JB, McKinna JA, Sinnett HD. Color Doppler signals from breast tumors: work in progress. Radiology 1990; 76:175-180.
24. Cosgrove D. Ultrasound contrast enhancement of tumours. Clin Radiol 1996; 51(suppl 1):44-49.
25. Jun WS, Lee KH, Koo K, et al. A straightforward algorithm for the quantification of power Doppler signals. Invest Radiol 2002; 37:343-348.
26. Park SH, Kim TK, Lee KH, et al. Quantitative comparison of tumor vascularity of hepatocellular carcinoma after intravenous contrast agent: conventional versus harmonic power Doppler US. Abdom Imaging 2001; 26:178-183.
27. Delorme S, Haberkorn U, Kinscherf R, Zuna I, Bahner ML, van Kaick G. Changes of tumor vascularity during gene therapy monitored with color Doppler US. Ultrasound Med Biol 2001; 27:1595-1603.
28. Strohmeyer D, Frauscher F, Klauser A, et al. Contrast-enhanced transrectal color Doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res 2001; 21:2907-2913.
29. Ogura O, Takebayashi Y, Sameshima T, et al. Preoperative assessment of vascularity by color Doppler ultrasonography in human rectal carcinoma. Dis Colon Rectum 2001; 44:538-546.
30. Brown JM, Quedens-Case C, Alderman JL, Greener Y, Taylor KJ. Contrast-enhanced sonography of tumor neovascularity in a rabbit model. Ultrasound Med Biol 1998; 24:495-501.
31. Imao T, Egawa M, Takashima H, Koshida K, Namiki M. Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma. Int J Urol 2004; 11:948-953.
32. Lassau N, Chawi I, Rouffiac V, Bidault S, Escudier B, Leclere J. Interest of color Doppler ultrasonography to evaluate a new anti-angiogenic treatment with thalidomide in metastatic renal cell carcinoma [abstract]. Bull Cancer 2004; 91:629-635.
33. Dalla Palma L, Bertolotto M. Introduction to ultrasound contrast agents: physics overview. Eur Radiol 1999, 9(suppl 3):S338-S342.
34. Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M, Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001, 11:1316-1328.